Isosorbide mononitrate chemical structure
Find information on thousands of medical conditions and prescription drugs.

Isosorbide mononitrate

Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris and acts by dilating the blood vessels so as to reduce the blood pressure.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
Ibuprofen
Idarubicin
Idebenone
IFEX
Iloprost
Imatinib mesylate
Imdur
Imipenem
Imipramine
Imiquimod
Imitrex
Imodium
Indahexal
Indapamide
Inderal
Indocin
Indometacin
Infliximab
INH
Inosine
Intal
Interferon gamma
Intralipid
Invanz
Invirase
Iontocaine
Iotrolan
Ipratropium bromide
Iproniazid
Irbesartan
Iressa
Irinotecan
Isocarboxazid
Isoflurane
Isohexal
Isoleucine
Isomonit
Isoniazid
Isoprenaline
Isordil
Isosorbide
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Itraconazole
Ivermectin
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Faulding receives US FDA Approval for immediate-release Isosorbide Mononitrate Tablets
From Business Wire, 11/2/98

ADELAIDE, South Australia--(BUSINESS WIRE)--Nov. 2, 1998-- International pharmaceutical and healthcare company, F H Faulding & Co Limited (Faulding), today announced that its US-based subsidiary, Purepac Pharmaceutical Co, part of Faulding Oral Pharmaceuticals, has received approval from the Food and Drug Administration (FDA) for its abbreviated new drug application for immediate-release isosorbide mononitrate tablets.

Mr Richard Moldin, Chief Executive Officer of Faulding Oral Pharmaceuticals, said, "Our 10mg and 20mg immediate-release isosorbide mononitrate tablets are the first generic equivalent of Monoket(R) brand tablets, marketed by Schwarz GMBH, to be approved by the FDA. The tablets are indicated for the prevention of angina pectoris due to coronary heart disease. The product had brand name sales in 1997 of approximately US$30 million. Purepac will commence commercial shipment of the product immediately."

The immediate-release isosorbide mononitrate tablets are the third FDA approval received by Faulding for the 1998/99 financial year, following the tentative approvals of diltiazem hydrochloride extended-release capsules and ticlopidine hydrochloride tablets.

Note: Monoket(R) is a registered trademark of Schwarz GMBH.

COPYRIGHT 1998 Business Wire
COPYRIGHT 2000 Gale Group

Return to Isosorbide mononitrate
Home Contact Resources Exchange Links ebay